[Essential hypertension: Definitions, hemodynamic, clinical and therapeutic review].
Vallée A, Safar ME, Blacher J.
Presse Med. 2019 Jan;48(1 Pt 1):19-28. doi: 10.1016/j.lpm.2018.11.017. Epub 2019 Jan 18.
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P.
Lancet Diabetes Endocrinol. 2018 Jan;6(1):41-50. doi: 10.1016/S2213-8587(17)30319-4. Epub 2017 Nov 9.
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Xie M, Tang T, Liang H.
Clin Cardiol. 2023 Aug;46(8):886-898. doi: 10.1002/clc.24082. Epub 2023 Jul 11.
Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.
Zhang Y, Zhao X, Huang H, Li M.
Clin Res Cardiol. 2023 Jul;112(7):855-867. doi: 10.1007/s00392-022-02120-0. Epub 2022 Nov 3.
Essential Hypertension and Functional Microvascular Ageing.
Bruno RM, Masi S, Taddei M, Taddei S, Virdis A.
High Blood Press Cardiovasc Prev. 2018 Mar;25(1):35-40. doi: 10.1007/s40292-017-0245-9. Epub 2018 Jan 9.
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial.
Lai X, Dong Z, Wu S, Zhou X, Zhang G, Xiong S, Wu W, Cao R, Wang X, Hua Q, Du J, Fan J, Mao J, Jiang W, Yuan H, Chen Y, Xu Y, Li Z, Zhang J, Dong G, Zhen H, Ding R, Wu Z, Gao Y.
Circ Cardiovasc Qual Outcomes. 2022 Mar;15(3):e007923. doi: 10.1161/CIRCOUTCOMES.121.007923. Epub 2022 Feb 2.
Early Programming of Adult Systemic Essential Hypertension.
Guarner-Lans V, Ramírez-Higuera A, Rubio-Ruiz ME, Castrejón-Téllez V, Soto ME, Pérez-Torres I.
Int J Mol Sci. 2020 Feb 11;21(4):1203. doi: 10.3390/ijms21041203.
'Essential' arterial hypertension: time for a paradigm change.
Rossi GP, Bagordo D, Rossi FB, Pintus G, Rossitto G, Seccia TM.
J Hypertens. 2024 Aug 1;42(8):1298-1304. doi: 10.1097/HJH.0000000000003767. Epub 2024 May 8.
[Spironolactone in resistant essential hypertension].
Lorthioir A, Belmihoub I, Fouassier D, Azizi M, Amar L.
Presse Med. 2019 Dec;48(12):1431-1438. doi: 10.1016/j.lpm.2019.07.027. Epub 2019 Aug 28.
Outpatient management of essential hypertension: a review based on the latest clinical guidelines.
Moiz A, Zolotarova T, Eisenberg MJ.
Ann Med. 2024 Dec;56(1):2338242. doi: 10.1080/07853890.2024.2338242. Epub 2024 Apr 11.
